Artelo Biosciences Files 8K - Other Events >ARTL

Artelo Biosciences Inc. (ARTL) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on October 09, 2026. On July 22, 2026, the Securities and Exchange Commission (the "SEC") approved The Nasdaq Stock Market LLC's ("Nasdaq") new listing compliance rule that requires listed companies to maintain a market value of listed securities ("MVLS") of at least $5,000,000 (the "$5M MVLS Rule"). Companies that fall below this threshold may be subject to delisting proceedings unless they can demonstrate a plan to regain compliance within a specified period. Approximately 180 companies listed on Nasdaq were initially identified as having an MVLS below the new threshold, including Artelo Biosciences, Inc. (the "Company"). On July 29, 2026, a temporary stay of the $5M MVLS Rule was announced. On October 5, 2026, the SEC published a notice from Nasdaq for a proposed rule change to modify the operative date of the $5M MVLS Rule to be upon termination of the temporary stay. Comments on the proposed rule change are due by October 29, 2026. As of the date of this filing, the Company has no information regarding how.